Skip to main content

Nuria Serre Delcor

I am a medical doctor at the Infectious Diseases Departament of the Vall Hebron Hospital, with a special interest in the diagnosis and prompt treatment of the most prevalent infectious diseases in travelers and migrants, as well as teaching and research in international health. I am the medical coordinator of the Center for International Health and Communicable Diseases in Drassanes-Vall d'Hebron.

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital
Nuria Serre Delcor

Nuria Serre Delcor

Nuria Serre Delcor

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

I am a medical doctor at the Infectious Diseases Departament of the Vall Hebron Hospital, with a special interest in the diagnosis and prompt treatment of the most prevalent infectious diseases in travelers and migrants, as well as teaching and research in international health. I am the medical coordinator of the Center for International Health and Communicable Diseases in Drassanes-Vall d'Hebron.

I was graduated in Medicine by the Universitat Autònoma of Barcelona (UAB) in 1996. Specialist in Family Doctor in 2000. Postgraduate in Mental Health in migrants at the Universitat de Barcelona (UB) in 2000. Postgraduate in Tropical Medicine in the Tropical Medicine Institute of Antwerp (Belgium) in 2001. Master in Epidemiology, Bahia Federal University (UFBA), Brazil, in 2003. Master's in international health at UB 2011. PhD in Medicine at UB in 2018. Lecturer at Tropical Medicine Master of the UAB. Director of the International Health Courses of PROSICS at Vall d’Hebron Hospital. Scientific coordinator of MyHealth, this project was co-founded by the EU from 2017 to 2020 and had the main goal of improving the quality and access to health for newly arrived migrants to Europe. Scientific PI from VHIR at ACTOVAX4NAM, this project is co-founded by the EU since 2021 and had the main goal of improving the vaccination coverage in newly arrived migrants to Europe. Since December 2022 I am the medical coordinator of the International Health and Infectious Diseases Center of Drassanes-Vall d'Hebron.

Projects

Identificación de biomarcadores de miocardiopatía chagásica mediante el uso de la metabolómica

IP: Israel Molina Romero
Collaborators: Pau Bosch Nicolau, Nuria Serre Delcor
Funding agency: Instituto de Salud Carlos III
Funding: 68970
Reference: PI19/01807
Duration: 01/01/2020 - 31/12/2023

Incorporació Dr. Israel Molina a la RETICS en Malalties tropicals

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Juan Espinosa Pereiro, Pau Bosch Nicolau, Nuria Serre Delcor, Fernando M Salvador Velez, Jordi Gómez i Prat, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 130542.5
Reference: RD16/0027/0003
Duration: 01/01/2017 - 30/06/2022

MyHealth: Models to engage Migrants and Refugees in their health, through Community Empowerment and Learning Alliance.

IP: Nuria Serre Delcor
Collaborators: Tahir Rafi Khanum, Estefa Choque Apaico, Abdallah Denial, Janna Anthonina Slabbekoorn, Esperanza Esteban Serna
Funding agency: Ex. Agency for Health Consumers (EAHC)-CHAFEA
Funding: 348276.86
Reference: MYHEALTH_3HP-CHAFEA2016
Duration: 01/04/2017 - 30/06/2020

Identificación de biomarcadores de miocardiopatía chagásica mediante el uso de la metabolómica.

IP: Israel Molina Romero
Collaborators: Begoña Treviño Maruri, Nuria Serre Delcor, Adrián Sánchez Montalvá
Funding agency: Instituto de Salud Carlos III
Funding: 52635
Reference: PI14/01825
Duration: 01/01/2015 - 31/12/2017

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Irene Buera Surribas

Irene Buera Surribas

Cardiovascular Diseases
Read more
María Jurado Ruiz

María Jurado Ruiz

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Paula Garcia Rodriguez

Paula Garcia Rodriguez

Research technician
Neurovascular Diseases
Read more
Daniel Alvarez De la Sierra

Daniel Alvarez De la Sierra

Research technician
Translational Immunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.